Free Trial

Molina Healthcare (MOH) Stock Forecast & Price Target

Molina Healthcare logo
$204.56 +7.64 (+3.88%)
Closing price 03:59 PM Eastern
Extended Trading
$202.74 -1.82 (-0.89%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Molina Healthcare - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
2
Hold
11
Buy
4

Based on 17 Wall Street analysts who have issued ratings for Molina Healthcare in the last 12 months, the stock has a consensus rating of "Hold." Out of the 17 analysts, 2 have given a sell rating, 11 have given a hold rating, 3 have given a buy rating, and 1 has given a strong buy rating for MOH.

Consensus Price Target

$202.44
-1.04% Downside
According to the 17 analysts' twelve-month price targets for Molina Healthcare, the average price target is $202.44. The highest price target for MOH is $286.00, while the lowest price target for MOH is $124.00. The average price target represents a forecasted downside of -1.04% from the current price of $204.57.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for MOH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Molina Healthcare and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MOH Analyst Ratings Over Time

TypeCurrent Forecast
10/12/25 to 10/12/26
1 Month Ago
9/12/25 to 9/12/26
3 Months Ago
7/14/25 to 7/14/26
1 Year Ago
10/12/24 to 10/12/25
Strong Buy
1 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
Hold
11 Hold rating(s)
12 Hold rating(s)
13 Hold rating(s)
9 Hold rating(s)
Sell
2 Sell rating(s)
2 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$202.44$202.44$197.31$228.18
Forecasted Upside-1.04% Downside-0.83% Downside-18.23% Downside17.66% Upside
Consensus RatingHoldHoldHoldHold

MOH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

MOH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Molina Healthcare Stock vs. The Competition

TypeMolina HealthcareHealthcare CompaniesBroader Market
Consensus Rating Score
2.18
2.32
2.53
Consensus RatingHoldHoldModerate Buy
Predicted Upside-1.04% Downside1,031.69% Upside19.25% Upside
News Sentiment Rating
Neutral News

See Recent MOH News
Positive News
Positive News
Report Date
0 Results
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
10/9/2026
Cantor Fitzgerald logo
Cantor Fitzgerald
5 of 5 stars
Sarah James
Sarah James
3 of 5 stars
Reiterated RatingNeutral
10/6/2026
Weiss Ratings logo
Weiss Ratings
3 of 5 stars
 DowngradeSell (D+) ➝ Sell (D)
9/22/2026
Zacks Research logo
Zacks Research
4 of 5 stars
 UpgradeHold ➝ Strong-Buy
7/28/2026Lower TargetEqual Weight$235.00 ➝ $220.00+10.07%
7/24/2026Lower TargetUnderweight$184.00 ➝ $180.00-10.14%
7/24/2026Lower TargetHold$250.00 ➝ $225.00+15.42%
7/24/2026Lower TargetSector Perform$248.00 ➝ $218.00+10.45%
7/14/2026 Set Target$230.00-5.06%
7/14/2026Boost TargetHold$163.00 ➝ $230.00-5.48%
7/13/2026 Set Target$286.00+19.75%
6/8/2026 Set Target$215.00+10.89%
6/8/2026Boost TargetNeutral$169.00 ➝ $191.00-2.77%
6/4/2026Boost TargetEqual Weight$146.00 ➝ $167.00-12.83%
5/22/2026Boost TargetNeutral$180.00 ➝ $202.00+11.67%
5/11/2026Boost TargetNeutral$124.00 ➝ $163.00-12.40%
4/29/2026 UpgradeUnderperform ➝ Buy$250.00+34.76%
4/24/2026 Reiterated RatingHold$129.00-23.33%
2/11/2026Lower TargetNeutral$167.00 ➝ $124.00+1.10%
4/9/2025Initiated CoverageNeutral
2/6/2025Reiterated RatingEqual Weight$345.00 ➝ $345.00+19.20%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 11:55 PM ET.


Should I Buy Molina Healthcare Stock? MOH Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, October 6, 2026. Please send any questions or comments about these Molina Healthcare pros and cons to contact@marketbeat.com.

Molina Healthcare
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Molina Healthcare, Inc.:

  • The stock is currently trading at $194.97, which is below the average analyst price target of $202.44, suggesting potential for price appreciation as the market digests recent earnings beats and guidance updates.
  • Molina Healthcare, Inc. recently reported second-quarter earnings of $1.51 per share, exceeding the consensus estimate of $1.39, demonstrating the company's ability to outperform analyst expectations despite a challenging operating environment.
  • The company has raised its full-year adjusted earnings guidance to at least $5.25 per share, indicating management confidence in its ability to maintain profitability even while managing significant headwinds in the Marketplace segment.
  • With a beta of 0.78, the stock exhibits lower volatility than the broader market, which may appeal to investors seeking a defensive position in the healthcare sector during periods of market uncertainty.
  • Institutional investors own 98.50% of the company's stock, reflecting strong confidence from large funds and professional money managers in the long-term stability and strategic direction of Molina Healthcare, Inc.

Molina Healthcare
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Molina Healthcare, Inc. for these reasons:

  • Wall Street Zen recently downgraded the stock from a "hold" to a "sell" rating, signaling a shift in sentiment among some analysts who are concerned about the company's current valuation and future growth prospects.
  • The company faces significant margin pressures, including a $1.50 per share loss from a new Florida Medicaid contract and a $1.00 per share loss from the traditional Medicare Advantage business it plans to exit in 2027, which could weigh on near-term profitability.
  • Molina Healthcare, Inc. expects Medicaid enrollment to decline to about 4.5 million members by year-end and Marketplace enrollment to fall to about 250,000, indicating a shrinking customer base that may limit revenue growth opportunities.
  • The company's price-to-earnings ratio is negative, reflecting recent accounting losses or low earnings relative to its market capitalization of $10.13 billion, which may deter value-oriented investors seeking stable, profitable companies.
  • Short interest has increased to 3.21 million shares, representing 6.24% of the float, suggesting that a significant portion of the market is betting against the stock's future performance due to lingering concerns about membership and margin trends.

MOH Forecast - Frequently Asked Questions

According to the research reports of 17 Wall Street equities research analysts, the average twelve-month stock price forecast for Molina Healthcare is $202.44, with a high forecast of $286.00 and a low forecast of $124.00.

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Molina Healthcare in the last twelve months. There are currently 2 sell ratings, 11 hold ratings, 3 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" MOH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MOH, but not buy additional shares or sell existing shares.

According to analysts, Molina Healthcare's stock has a predicted downside of -1.04% based on their 12-month stock forecasts.

Over the previous 90 days, Molina Healthcare's stock had 4 downgrades and 3 upgrades by analysts.

Molina Healthcare has been rated by research analysts at Barclays, Cantor Fitzgerald, Jefferies Financial Group, Royal Bank Of Canada, TD Cowen, Truist Financial, Weiss Ratings, Wells Fargo & Company, and Zacks Research in the past 90 days.

Analysts like Molina Healthcare less than other "healthcare" companies. The consensus rating score for Molina Healthcare is 2.18 while the average consensus rating score for "healthcare" companies is 2.32. Learn more on how MOH compares to other companies.


MarketBeat monitors more than a dozen sources for Molina Healthcare analyst ratings, with the most recent rating issued on 10/9/2026.
From Our Partners